MoneyWorks4Me

A fair growth of 11.58% in the revenue at Rs. 1337.66 millions was reported in the December 2022 quarter as compared to Rs. 1198.80 millions during year-ago period.A slim rise of 22.80% was recorded in the Net profit for the quarter ended December 2022 to Rs. 216.14  millions  From Rs. 176.01 millions.Operating Profit saw a handsome growth to 331.10 millions from 260.85 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1337.66 1198.80 11.58 3978.49 3695.37 7.66 4720.79 4229.08 11.63
Other Income 63.58 26.35 141.29 185.38 81.07 128.67 99.98 57.43 74.09
PBIDT 331.10 260.85 26.93 911.09 861.40 5.77 1054.68 927.83 13.67
Interest 3.31 3.05 8.52 8.81 8.84 -0.34 14.51 15.52 -6.51
PBDT 327.79 257.80 27.15 902.28 852.56 5.83 1040.17 912.31 14.01
Depreciation 22.62 21.81 3.71 67.53 60.90 10.89 80.88 75.60 6.98
PBT 305.17 235.99 29.31 834.75 791.66 5.44 959.29 836.71 14.65
TAX 89.03 59.98 48.43 231.37 208.36 11.04 265.74 214.21 24.06
Deferred Tax 4.36 2.46 77.24 5.75 1.56 268.59 7.20 2.47 191.50
PAT 216.14 176.01 22.80 603.38 583.30 3.44 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 24.75 21.76 13.75 22.90 23.31 -1.76 22.34 21.94 1.83
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..